Need professional-grade analysis? Visit stockanalysis.com
$186.91M
N/A
N/A
N/A
Profound Medical Corp (PROF) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at $6.65, up 0.45% from the previous close.
Over the past year, PROF has traded between a low of $3.87 and a high of $8.65. The stock has gained 42.4% over this period. It is currently 23.1% below its 52-week high.
Profound Medical Corp has a market capitalization of $186.91M.
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.
Side-by-side comparison against top Healthcare peers.